CareCloud to Present at the 2025 Maxim Growth Summit

Rhea-AI Summary

CareCloud (Nasdaq: CCLD) will present at the 2025 Maxim Growth Summit on October 22–23, 2025 at the Hard Rock Hotel New York City.

Presentation will highlight recent M&A activity (four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier this month), the Company’s AI roadmap and AI Center of Excellence scaling toward ~500 AI professionals, raised 2025 revenue guidance to $116–$118 million, positive free cash flow, resumption of preferred dividends, and inclusion in the Russell Microcap Index.

Company to highlight acquisitions, growth and AI roadmap

SOMERSET, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”) today announced its participation in the 2025 Maxim Growth Summit, taking place October 22–23, 2025 at the Hard Rock Hotel New York City. This event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several leading industries, including technology and healthcare.

Earlier this year, Maxim Group named CareCloud its ‘Top Healthcare IT Pick for 2025,’ citing the transformative potential of our AI strategy, strong financial results, and renewed M&A activity. Maxim’s report also highlighted the Company’s AI Center of Excellence, positive free cash flow, and resumption of preferred dividends earlier in 2025.

Discussion topics for Maxim investors

• M&A momentum: Four transactions closed year-to-date including the transformative Medsphere acquisition in late August and the Company’s most recent acquisition of HFMA’s MAP App earlier this month.
• AI Center of Excellence: Launched earlier this year and scaling toward ~500 AI professionals to accelerate innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement.
• 2025 outlook: Revenue guidance raised to $116–$118 million on strong execution.
• Index inclusion: Added to the Russell Microcap^® Index, broadening investor awareness.

For more information and a complete agenda of the Maxim Growth Summit, please visit www.maximgrp.com/2025-growth-summit.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.

Follow CareCloud on LinkedIn, X and Facebook.

For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.

Forward-Looking Statements

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE: CareCloud

Company Contact: 
Norman Roth 
Interim Chief Financial Officer and Corporate Controller 
CareCloud, Inc.
nroth@carecloud.com 

Investor Contact:
Stephen Snyder 
Co-Chief Executive Officer 
CareCloud, Inc. 
ir@carecloud.com 

FAQ

When will CareCloud (CCLD) present at the 2025 Maxim Growth Summit?

CareCloud will present on October 22–23, 2025 at the Hard Rock Hotel New York City.

What M&A updates will CareCloud (CCLD) discuss at the Maxim Growth Summit?

CareCloud will discuss four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier in October 2025.

What 2025 guidance did CareCloud (CCLD) provide ahead of the Maxim Growth Summit?

CareCloud raised its 2025 revenue guidance to $116–$118 million.

What is CareCloud’s AI Center of Excellence update investors should expect (CCLD)?

The AI Center of Excellence was launched earlier in 2025 and is scaling toward ~500 AI professionals to support EHR, RCM, analytics, and patient engagement.

How has CareCloud (CCLD) signaled shareholder confidence before the Maxim Growth Summit?

CareCloud reported positive free cash flow and resumed payment of preferred dividends earlier in 2025.

Where can investors find the Maxim Growth Summit agenda and CareCloud’s presentation details?

The full agenda and event details are available on the Maxim Growth Summit website at www.maximgrp.com/2025-growth-summit.